During the past decade, Comprehensive Cardiovascular Specialists conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Cardiovascular Specialists" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Cardiovascular Specialists" are "Acute Coronary Syndromes" (1 trials), "Anti-coagulation Therapy" (1 trials), "Atrial Fibrillation" (1 trials), "DVT" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Comprehensive Cardiovascular Specialists" in a lesser frequency.

Most popular intervention types in "Comprehensive Cardiovascular Specialists" are "Device" (3 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials), "Apixaban" (1 trials), "Arm 1 (ATP+Shock)" (1 trials) and "Arm 2 (shock only)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Cardiovascular Specialists" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Comprehensive Cardiovascular Specialists". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Comprehensive Cardiovascular Specialists, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Cardiovascular Specialists, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".